Fortress Biotech, Inc. (NASDAQ:FBIOP) Short Interest Update

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 840 shares, an increase of ? from the July 15th total of 0 shares. Based on an average daily volume of 8,927 shares, the short-interest ratio is currently 0.1 days.

Fortress Biotech Trading Down 2.4%

FBIOP stock traded down $0.45 during trading on Friday, reaching $18.66. The stock had a trading volume of 40,432 shares, compared to its average volume of 21,796. Fortress Biotech has a one year low of $6.27 and a one year high of $21.43. The company’s 50 day moving average is $19.52 and its two-hundred day moving average is $15.96.

Fortress Biotech Company Profile

Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.

The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.